Ha kapcsolatba szeretne lépni a Tudóstér adminisztrátoraival, kérjük töltse ki az alábbi űrlapot, vagy küldjön e-mailt a publikacioklib.unideb.hu címre.
Bejelentkezés
A Tudóstér funkcióinak nagy része bejelentkezés nélkül is elérhető. Bejelentkezésre az alábbi műveletekhez van szükség:
Debreceni Egyetem. Általános Orvostudományi Kar. Orvosi Klinikai Farmakológiai Tanszék / University of Debrecen. Faculty of Medicine. Department of Clinical Pharmacology in Medicine
Nagy, D. T.,
Fülesdi, B.,
Kozma, B.,
Páll, D.,
Szatmári, S.,
Hupuczi, P.:
Assessment of Cerebral Hemodynamic Changes During Roll-Over Test in Healthy Pregnant Women and Those with Mild and Severe Preeclampsia.
J Clin Med. 14 (4), 1-9, (cikkazonosító: 1182), 2025.
Kushner, R. F.,
Ryan, D. H.,
Deanfield, J.,
Kokkinos, A.,
Cercato, C.,
Wilding, J. P. H.,
Burguera, B.,
Wu, C. C.,
Craciun, A. E.,
Páll, D.,
Hramiak, I.,
Hjelmesth, J.,
Harder-Lauridsen, N. M.,
Weimers, P.,
Jeppesen, O. K.,
Kallenbach, K.,
Lincoff, A. M.,
Lingvay, I.:
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.
Obesity. 33, 452-462, 2025.
Bäck, M.,
Topouchian, J.,
Labat, C.,
Gautier, S.,
Blacher, J.,
Cwynar, M.,
Sierra, A. d. l.,
Páll, D.,
Duarte, K.,
Fantin, F.,
Farkas, K.,
Garcia-Ortiz, L.,
Hakobyan, Z.,
Jankowski, P.,
Jelakovic, A.,
Kotsani, M.,
Konrádi, A.,
Mikhailova, O.,
Mintale, I.,
Plunde, O.,
Ramos, R.,
Rogoza, A.,
Sirenko, Y.,
Tasic, N.,
Rudyk, I.,
Urazalina, S.,
Wohlfahrt, P.,
Zelveian, P.,
Asmar, R.,
Benetos, A.:
Cardio-ankle vascular index for predicting cardiovascular morbimortality and determinants for its progression in the prospective advanced approach to arterial stiffness (TRIPLE-A-Stiffness) study.
EBioMedicine. [Epub ahead of print], 2024.
Nemcsik, J.,
Takács, J.,
Pásztor, D.,
Farsang, C.,
Simon, A.,
Páll, D.,
Torzsa, P.,
Dolgos, S.,
Koller, Á.,
Habony, N.,
Járai, Z.:
Frequency of office blood pressure measurements and the seasonal variability of blood pressure: results of the Hungarian Hypertension Registry.
Blood Press. 33 (1), 1-8, 2024.
Gaudet, D.,
Páll, D.,
Watts, G. F.,
Nicholls, S. J.,
Rosenson, R. S.,
Modesto, K.,
San Martin, J.,
Hellawell, J.,
Ballantyne, C. M.:
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: the SHASTA-2 Randomized Clinical Trial.
JAMA Cardiol. [Epub ahead of print], 2024.
Nemcsik, J.,
Takács, J.,
Kekk, Z.,
Farsang, C.,
Simon, A.,
Páll, D.,
Torzsa, P.,
Dolgos, S.,
Habony, N.,
Koller, Á.,
Pásztor, D.,
Járai, Z.:
White-coat effect and masked hypertension in patients with high-normal office blood pressure: results of the Hungarian ABPM Registry.
J. Hypertens. [Epub ahead of print], 2024.
Lurbe, E.,
Mancia, G.,
Calpe, J.,
Drożdż, D.,
Erdine, S.,
Fernandez-Aranda, F.,
Hadjipanayis, A.,
Hoyer, P. F.,
Jankauskiene, A.,
Jiménez-Murcia, S.,
Litwin, M.,
Mazur, A.,
Páll, D.,
Seeman, T.,
Sinha, M. D.,
Simonetti, G.,
Stabouli, S.,
Wühl, E.:
Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. How to correctly measure blood pressure in children and adolescents.
Front. Pediatr. 11, 1-9, (cikkazonosító: 1140357), 2023.
Wühl, E.,
Calpe, J.,
Drożdż, D.,
Erdine, S.,
Fernandez-Aranda, F.,
Hadjipanayis, A.,
Hoyer, P. F.,
Jankauskiene, A.,
Jiménez-Murcia, S.,
Litwin, M.,
Mancia, G.,
Mazur, A.,
Páll, D.,
Seeman, T.,
Sinha, M. D.,
Simonetti, G.,
Stabouli, S.,
Lurbe, E.:
Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 2. How to manage high blood pressure in children and adolescents.
Front. Pediatr. 11, 1-10, (cikkazonosító: 1140617), 2023.
Q2
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
Medicine (miscellaneous)
17.
Köbling, T.,
Maroda, L.,
Katona, É.,
Váradi, Z.,
Somodi, S.,
Páll, D.,
Zrínyi, M.:
Discriminating low to high adherent type 2 patients with diabetes by glycosylated hemoglobin A1c, eating self-efficacy and other psychosocial determinants: difference between patient and physician adherence models.
Patient Prefer. Adher. 16, 1405-1414, 2022.
Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q1
Social Sciences (miscellaneous)
18.
Girardi, P.,
Harutyunyan, S.,
Neuhauser, I.,
Glaninger, K.,
Korda, O.,
Nagy, G.,
Nagy, E.,
Szíjártó, V.,
Páll, D.,
Szarka, K.,
Kardos, G.,
Henics, T.,
Malinoski, F. J.:
Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial.
Vaccines. 10 (2), 1-15, (cikkazonosító: 340), 2022.
Redon, J.,
Seeman, T.,
Páll, D.,
Suurorg, L.,
Kamperis, K.,
Erdine, S.,
Wühl, E.,
Mancia, G.:
Narrative update of clinical trials with antihypertensive drugs in children and adolescents.
Front. Cardiovasc. Med. 9, 1-12, 2022.
Das Pradhan, A.,
Glynn, R. J.,
Fruchart, J. C.,
MacFadyen, J. G.,
Zaharris, E. S.,
Everett, B. M.,
Campbell, S. E.,
Oshima, R.,
Amarenco, P.,
Blom, D. J.,
Brinton, E. A.,
Eckel, R. H.,
Elam, M. B.,
Felicio, J. S.,
Ginsberg, H. N.,
Goudev, A.,
Ishibashi, S.,
Joseph, J.,
Kodama, T.,
Koenig, W.,
Leiter, L. A.,
Lorenzatti, A. J.,
Mankovsky, B. N.,
Marx, N.,
Nordestgaard, B. G.,
Páll, D.,
Ray, K. K.,
Santos, R. D.,
Soran, H.,
Susekov, A.,
Tendera, M.,
Yokote, K.,
Paynter, N. P.,
Buring, J. E.,
Libby, P.,
Ridker, P. M.,
PROMINENT Investigators:
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N. Engl. J. Med. 387 (21), 1923-1934, 2022.
